Dogansen Sema Ciftci, Yalin Gulsah Yenidunya, Canbaz Bulent, Tanrikulu Seher, Yarman Sema
Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Division of Endocrinology and Metabolism, Istanbul, Turkey.
Arch Endocrinol Metab. 2018 Apr 5;62(2):164-171. doi: 10.20945/2359-3997000000019. Print 2018 Mar-Apr.
The aim of this study was to determine the frequency of central thyroid dysfunctions in Cushing's syndrome (CS). We also aimed to evaluate the frequency of hyperthyroidism due to the syndrome of the inappropriate secretion of TSH (SITSH), which was recently defined in patients with insufficient hydrocortisone replacement after surgery.
We evaluated thyroid functions (TSH and free thyroxine [fT4]) at the time of diagnosis, during the hypothalamo-pituitary-adrenal axis recovery, and after surgery in 35 patients with CS. The patients were separated into two groups: ACTH-dependent CS (group 1, n = 20) and ACTH-independent CS (group 2, n = 15). Patients' clinical and laboratory findings were evaluated in five visits in the outpatient clinic of the endocrinology department.
The frequency of baseline suppressed TSH levels and central hypothyroidism were determined to be 37% (n = 13) and 26% (n = 9), respectively. A negative correlation was found between baseline cortisol and TSH levels (r = -0.45, p = 0.006). All patients with central hypothyroidism and suppressed TSH levels showed recovery at the first visit without levothyroxine treatment. SITSH was not detected in any of the patients during the postoperative period. No correlation was found between prednisolone replacement after surgery and TSH or fT4 levels on each visit.
Suppressed TSH levels and central hypothyroidism may be detected in CS, independent of etiology. SITSH was not detected in the early postoperative period due to our adequate prednisolone replacement doses.
本研究旨在确定库欣综合征(CS)患者中枢性甲状腺功能障碍的发生率。我们还旨在评估促甲状腺激素不适当分泌综合征(SITSH)所致甲状腺功能亢进的发生率,该综合征最近在术后氢化可的松替代不足的患者中被定义。
我们评估了35例CS患者在诊断时、下丘脑 - 垂体 - 肾上腺轴恢复期间及术后的甲状腺功能(促甲状腺激素[TSH]和游离甲状腺素[fT4])。患者被分为两组:促肾上腺皮质激素(ACTH)依赖性CS(第1组,n = 20)和ACTH非依赖性CS(第2组,n = 15)。在内分泌科门诊对患者进行了五次就诊时的临床和实验室检查结果评估。
基线时TSH水平被抑制和中枢性甲状腺功能减退的发生率分别确定为37%(n = 13)和26%(n = 9)。发现基线皮质醇水平与TSH水平之间存在负相关(r = -0.45,p = 0.006)。所有中枢性甲状腺功能减退且TSH水平被抑制的患者在首次就诊时未接受左甲状腺素治疗即显示恢复。术后期间未在任何患者中检测到SITSH。术后泼尼松龙替代剂量与每次就诊时的TSH或fT4水平之间未发现相关性。
在CS中可能检测到TSH水平被抑制和中枢性甲状腺功能减退,与病因无关。由于我们给予了足够的泼尼松龙替代剂量,术后早期未检测到SITSH。